FDA green lights Stimwave’s mini spinal cord stimulator | Regulatory news for the week of December 8, 2014
Legal: AngioDynamics settles distro spat with Cardinal Health
AngioDynamics (NSDQ:ANGO) closed the books on a 3-year-old distribution spat with Cardinal Health, with the companies agreeing to a terminate the lawsuit late last month.
AngioDynamics offers updates on fleet of lawsuits
In additional to touting a 53% spike in sales, AngioDynamics’ (NSDQ:ANGO) 1st-quarter earnings report detailed a raft of ongoing lawsuits over infringed patents, jilted employees and soured distribution agreements.
AngioDynamics names Navilyst exec chief tech officer post-merger | Personnel Moves
Abiomed slides on reimbursement risk rumors | Wall Street Beat
Smokers in China tip the scale in med-tech’s favor | Wall Street Beat
The Chinese medical device market may triple by 2018, partially due to high rates of tobacco consumption and a rapidly growing economy, according to a market report.
AngioDynamics details $372M Navilyst buyout details | Wall Street Beat
Financial projections from AngioDynamics (NSDQ:ANGO) about its $372 million deal to acquire Navilyst Medical show that it expects to reap some significant rewards from the merger over the short and long terms.
MassDevice.com +3 | The top 3 med-tech stories for February 2, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
AngioDynamics CEO: Navilyst deal hits the reset button | Wall Street Beat
Updated February 1, 2012 at 5:30 p.m.
The $372 million buyout of Navilyst Medical by AngioDynamics (NSDQ:ANGO) is a reset button that will reinforce the combined operation for the future, AngioDynamics CEO Joe DeVivo told MassDevice this afternoon.
AngioDynamics to pay $372M for Navilyst Medical
Guide Flow sues BD, five others over catheter patent
Guide Flow LLC filed a lawsuit against six other firms, accusing them of infringing its patent for a "Catheter Guidewire and Flushing Apparatus and Method of Insertion."
The Newport Beach, Calif.-based firm accused C.R. Bard Inc. (NYSE:BCR), AngioDynamics Inc. (NSDQ:ANGO), Becton, Dickinson & Co. (NYSE:BDX), Medical Components Inc., Navilyst Medical Inc. and Smiths Medical ASD Inc. of violating the patent in a suit filed in the U.S. District Court for Utah.
